Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

180 Life Sciences Corp. - Common Stock (NQ:ATNF)

1.146 +0.066 (+6.09%)
Streaming Delayed Price Updated: 10:48 AM EDT, May 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about 180 Life Sciences Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Why 180 Life Sciences Stock Is Getting Hammered
180 Life Sciences Corp (NASDAQ: ATNF) shares are trading lower by 18.3% to $0.69 Thursday morning after the company announced pricing of a $3 million public offering. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
180 Life Sciences Corp. Announces Pricing of $3 Million Public Offering
From 180 Life Sciences Corp.
Via GlobeNewswire
Why AppLovin Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket
Gainers PHAXIAM Therapeutics S.A. (NASDAQ: PHXM) shares surged 46.7% to $0.64 in pre-market trading after gaining 6% on Wednesday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting off the day with a breakdown of the biggest pre-market stock movers traders should watch on Thursday morning! 
Via InvestorPlace
PENN Stock Alert: The $2 Billion Reason Penn Entertainment Is Up Today
Penn Entertainment (PENN) stock is rising higher on Wednesday after the company signed a massive deal with Disney's (DIS) ESPN. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Is Nxu (NXU) Stock Down 32% Today?
Nxu (NXU) stock is taking a beating on Wednesday after the power storage company announced pricing of a public share offering. 
Via InvestorPlace
Why Is Doximity (DOCS) Stock Down 23% Today?
Doximity (DOCS) stock is falling hard on Wednesday after the medical cloud services company released earnings for fiscal Q1 2024! 
Via InvestorPlace
Why EMCORE Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Gainers 180 Life Sciences Corp. (NASDAQ: ATNF) shares surged 109.2% to $1.58 in pre-market trading after falling over 6% on Tuesday. 
Via Benzinga
Why Is 180 Life Sciences (ATNF) Stock Up 38% Today?
180 Life Sciences (ATNF) stock is climbing higher on Wednesday as the cannabis market undergoes a rally alongside strong earnings! 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to start Wednesday with an overview of all the biggest pre-market stock movers traders need to know about this morning! 
Via InvestorPlace
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Enters Agreement for Strategic PK Study
Via Investor Brand Network
Topics Derivatives
Exposures Derivatives
180 Life Sciences Teams Up With Hadassah Hospital To Test A New Formulation Of CBD For Enhanced Oral Uptake
180 Life Sciences Corp. 
Via Benzinga
180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral Uptake
From 180 Life Sciences Corp.
Via GlobeNewswire
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Issues Update on Regulatory Approval Process for Dupuytren’s Disease Treatment
Via Investor Brand Network
180 Life Sciences Provides Update on Regulatory Approval Process in the UK and US for Dupuytren’s Disease Treatment; Continues Consultations with the UK MHRA and Initiates a Type C Meeting Request With the US FDA
From 180 Life Sciences Corp.
Via GlobeNewswire
180 Life Sciences Files A Provisional Patent For CBD-Based Appetite Suppressant
180 Life Sciences Corp. (NASDAQ: ATNF) filed a provisional patent describing the novel combination of CBD, or an analog thereof, with glucagon related peptide-1 (GLP-1) agonists to address the problem... 
Via Benzinga
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces the Filing of a Provisional Patent Describing the Combination of CBD With GLP-1 Agonists to Suppress Appetite
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
180 Life Sciences Corp. Announces the Filing of a Provisional Patent Describing the Combination of CBD With GLP-1 Agonists to Suppress Appetite
From 180 Life Sciences Corp.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Foot Locker Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Monogram Orthopaedics Inc. (NASDAQ: MGRM) shares climbed 148.3% to $29.18 after jumping 62% on Thursday. Monogram Orthopaedics raised $17,216,147 through the sale of 2,374,641 shares of its... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday saw 59 companies set new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Closes on $3M Registered Direct Offering, Concurrent Private Placement
Via Investor Brand Network
180 Life Sciences Corp. Announces Closing of $3 Million Registered Direct Offering and Concurrent Private Placement
From 180 Life Sciences Corp.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces $3M Registered Direct, Concurrent Private Placement
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.